Initial treatment of renal bone disease and cinacalcet for secondary hyperparathyroidism
Phosphate binders reduce hyperphosphataemia and hyperparathyroidism. Calcium-containing phosphate binders also improve hypocalcaemia. 


Calcitriol improves hypocalcaemia and hyperparathyroidism.


Addition of cinacalcet to the first-line treatments inhibits PTH release. This decreases secondary hyperparathyroidism which reduces bone turnover and associated electrolyte disturbances.


#Pharmacology #Pathophysiology #Secondary #Hyperparathyroidism #Sensipar #Cinacalcet #Calcitriol